References
Shoulson I, Glaubiger GA, Chase TN (1975) On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology 25:1144–1148
Nyholm D, Nilsson Remahl AI et al (2005) Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 64:216–223
Nyholm D, Constantinescu R, Holmberg B, Dizdar N, Askmark H (2009) Comparison of apomorphine and levodopa infusions in four patients with Parkinson’s disease with symptom fluctuations. Acta Neurol Scand 119:345–348
Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR (2009) Intrajejunal levodopa infusion in Parkinson’s disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 24:1468–1474
Odin P, Wolters E, Antonini A (2008) Continuous dopaminergic stimulation achieved by duodenal levodopa infusion. Neurol Sci 29(Suppl 5):S387–S388
Antonini A, Isaias IU, Canesi M, Zibetti M, Mancini F, Manfredi L, Dal Fante M, Lopiano L, Pezzoli G (2007) Duodenal levodopa infusion for advanced Parkinson’s disease: 12-month treatment outcome. Mov Disord 22:1145–1149
Devos D (2009) Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson’s disease. Mov Disord 24:993–1000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klostermann, F., Jugel, C. & Marzinzik, F. Benefit from jejunal levodopa in a patient with apomorphine pump. J Neurol 258, 311–312 (2011). https://doi.org/10.1007/s00415-010-5698-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-010-5698-x